Update: Following the success of EcoPrime Twin and CaptureSMB in the marketplace, YMC has acquired LEWA’s EcoPrime Twin platform and the ChromaCon business in 2018 and 2019, respectively, further strengthening the combined portfolio of continuous chromatography solutions for bioprocessing.
Zurich, Switzerland and Groton, CT, USA – May 8, 2018.
LEWA’s EcoPrime Twin continuous chromatography system, featuring ChromaCon’s CaptureSMB® technology, has received the Aspen Award for the Advancement of Downstream Processing 2017. The award is presented by Aspen Brook, the organization behind AspenXchange and the widely read Aspen Alert newsletter, which reaches more than 50,000 biotechnology professionals worldwide.
The Aspen Award recognizes technologies and teams that significantly advance downstream bioprocessing. By combining LEWA’s EcoPrime Twin system with ChromaCon’s patented CaptureSMB twin-column continuous chromatography, biopharmaceutical manufacturers can increase productivity, resin utilization and yield while maintaining high product quality — from process development through GMP manufacturing scale.
Michael Bavand, CEO of ChromaCon, commented:
“We are very happy and congratulate LEWA on this prestigious award. The collaboration between our companies has been a great success. The implementation of continuous chromatography at GMP production scale, now being implemented at major biopharma customers at pilot and production scale, confirms the benefit of continuous processing.”
A key milestone in the industrial adoption of CaptureSMB was reached when Bristol-Myers Squibb published the successful scale-up of ChromaCon’s CaptureSMB process in BioProcess International. The work demonstrates how twin-column periodic countercurrent chromatography can be used for efficient monoclonal antibody (mAb) purification in a GMP environment. The article is available at: BioProcess International – Scale-up of Twin-Column Periodic Countercurrent Chromatography for mAb Purification.
About ChromaCon
ChromaCon AG is a private life science tools company based in Zürich, Switzerland, providing best-in-class laboratory chromatography equipment and process solutions to the biopharmaceutical industry. The company has developed and patented novel process principles, process control and simulation software, equipment designs and operating software for batch, cyclic and continuous chromatography.
These process solutions enable significant CAPEX and OPEX savings and scalable chromatographic solutions for large-scale purification applications. ChromaCon’s Contichrom® laboratory-scale systems are co-marketed worldwide together with its partners. ChromaCon has granted global licenses for its process technologies to LEWA (Devens, MA, USA) for implementation into scale-up systems.
About LEWA Bioprocess Technologies Group
The LEWA Bioprocess Technologies Group of LEWA-Nikkiso develops advanced downstream bio/pharmaceutical processing platforms. Its systems can replace up to three competitive units in a smaller footprint.
By combining deep expertise in fluid dynamics with industry-leading pump technology, LEWA provides precise solutions for processes ranging from batch to fully continuous bioprocessing, ensuring an optimal balance of accuracy, repeatability and precision. LEWA’s design, fabrication and automation services offer a single, vertically integrated supply chain to help customers get online faster.
Contact
ChromaCon Contact
To find out more about ChromaCon, please contact us directly or visit our website:
Thomas Müller-Späth, CEO – – www.chromacon.com
YMC America Contact
To find out more about LEWA Bioprocess Technologies Group, please contact them directly or visit their website:
sales@ymcamerica.com – www.ymcamerica.com
